Carlos
Gamallo Amat
Publicaciones en las que colabora con Carlos Gamallo Amat (11)
2012
-
Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer
Tumori, Vol. 98, Núm. 3, pp. 364-369
2011
-
Identification of prognostic factors in pancreatic cancer
Cirugia y Cirujanos, Vol. 79, Núm. 4, pp. 338-348
2010
-
Impacto de los niveles preoperatorios de hemoglobina y albúmina en la supervivencia del carcinoma de páncreas
Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 11, pp. 631-636
-
Influence of thymidylate synthase DNA polymorphisms and gender on the clinical evolution of patients with advanced colorectal cancer
Oncology Reports, Vol. 23, Núm. 5, pp. 1393-1400
-
Role of intratumoral lymphatic vessels in the lymph node dissemination of laryngopharyngeal squamous cell carcinoma
Head and Neck, Vol. 32, Núm. 6, pp. 757-762
2009
-
Combination of polymorphisms within 5′ and 3′ untranslated regions of thymidylate synthase gene modulates survival in 5 flourouracil-treated colorectal cancer patients
International Journal of Oncology, Vol. 34, Núm. 1, pp. 219-229
-
Polymorphisms in the hypoxia inducible factor 1-α and the impact on the prognosis of early stages of oral cancer
Annals of Surgical Oncology, Vol. 16, Núm. 8, pp. 2351-2358
2007
-
Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 N0 laryngopharyngeal squamous cell carcinoma
Annals of Surgical Oncology, Vol. 14, Núm. 1, pp. 248-257
2006
-
Thymidylate synthase expression pattern, expression level and single nucleotide polymorphism are predictors for disease-free survival in patients of colorectal cancer treated with 5-fluorouracil
International Journal of Oncology, Vol. 28, Núm. 5, pp. 1303-1310
2005
-
P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: An indicator of poor prognosis
Cancer, Vol. 103, Núm. 5, pp. 960-969
2004
-
Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil.
International journal of oncology, Vol. 25, Núm. 4, pp. 877-885